The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is ...

BioMark Strengthens Liquid Biopsy Platform for Breast Cancer Detection Vancouver, British Columbia--( - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) ("BioMark"), ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the ...

Bio-Techne Corporation today announced the release of clinically relevant spatial biology data. The data was generated using Bio-Techne's Lunaphore branded end-to-end spatial biology offering, ...

Viatris Inc. today announced that on November 4, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The ...

A new immune cell biomarker has been discovered that can predict the effectiveness of immune anticancer treatment in patients ...

Pascale, and leading AI-powered spatial biomarker and diagnostics company ... At this year's Society for Immunotherapy of Cancer's (SITC) Annual Meeting novel data sets will be presented, showcasing ...

As healthcare rapidly advances, AI-driven technologies present compelling investment opportunities. Hence, investors might ...

At this time, I would like to welcome everyone to Karyopharm Therapeutics third quarter 2024 financial results conference ...

Maria L. Padilla, MD, Icahn School of Medicine at Mount Sinai, previews that experts will discuss critical management strategies for interstitial lung disease and idiopathic pulmonary fibrosis, ...

Breast cancer screening helps people live longer. Screening can catch cancer early, either in the precancerous stage or when ...